Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study (Q43748985)
Jump to navigation
Jump to search
scientific article published in October 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study |
scientific article published in October 2001 |
Statements
1 reference
Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study (English)
1 reference
N Hotta
1 reference
T Toyota
1 reference
K Matsuoka
1 reference
Y Shigeta
1 reference
R Kikkawa
1 reference
T Kaneko
1 reference
A Takahashi
1 reference
K Sugimura
1 reference
Y Koike
1 reference
J Ishii
1 reference
N Sakamoto
1 reference
SNK-860 Diabetic Neuropathy Study Group
1 reference
1 October 2001
1 reference
1 reference
Identifiers
1 reference